2.21
4.74%
0.10
Dopo l'orario di chiusura:
2.30
0.09
+4.07%
Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
4.76%
0.022
|
0.021 | 0.022 | 0.022 | 0.03 |
Operating Expenses
|
18.33%
69.53
|
85.13 | 63.02 | 80.56 | 99.12 |
Benefits Costs and Expenses |
24.22%
65.02
|
85.80 | - | - | 100.00 |
Costs And Expenses |
24.22%
65.02
|
85.80 | 63.02 | 80.56 | 100.00 |
Operating Income/Loss |
18.34%
-69.50
|
-85.11 | -63.00 | -80.54 | -99.09 |
Nonoperating Income/Loss |
773.24%
4.504
|
-0.669 | 0.709 | 1.308 | -0.876 |
Income/Loss Before Equity Method Investments |
-64.07
|
- | - | - | - |
Income/Loss From Equity Method Investments |
-0.929
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
24.22%
-65.00
|
-85.78 | 0.022 | 0.022 | -99.97 |
Income/Loss From Continuing Operations After Tax |
24.22%
-65.00
|
-85.78 | -62.29 | -79.23 | -99.97 |
Net Income/Loss
|
24.22%
-65.00
|
-85.78 | -62.29 | -79.23 | -99.97 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,299%
169.13
|
3.8443 | 167.65 | 146.80 | 144.56 |
Diluted Average Shares |
4,299%
169.13
|
3.8443 | 167.65 | 146.80 | 144.56 |
Basic Earnings Per Share |
25.49%
-0.38
|
-0.51 | -0.37 | -0.54 | -0.69 |
Diluted Earnings Per Share |
25.49%
-0.38
|
-0.51 | -0.37 | -0.54 | -0.69 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):